Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Public ClinicalTrials.gov record NCT07819435. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Multicenter, Double-blind, Vehicle-controlled, Phase 2/3 Study to Assess Efficacy and Long-Term Safety of PP405 in Adult Males With Androgenetic Alopecia
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The study is designed to validate efficacy and long term safety of PP405.
Study identification
- NCT ID
- NCT07819435
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 600 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 21, 2026 (Actual)
- Primary completion
- Dec 2027 (Estimated)
- Completion
- Jun 2028 (Estimated)
- Last update posted
- Oct 2, 2026
2026 – 2028
United States locations
- U.S. sites
- 16
- U.S. states
- 11
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Johnson Dermatology | Fort Smith | Arkansas | 72916 | Recruiting |
| Burke Pharmaceutical Research | Hot Springs | Arkansas | 71913 | Recruiting |
| Ablon Skin Institute and Research Center | Manhattan Beach | California | 90266 | Recruiting |
| Clinical Trials Research Institute | Thousand Oaks | California | 91230 | Recruiting |
| Skin Research Institute, LLC | Coral Gables | Florida | 33146 | Recruiting |
| MOORE Clinical Research, Inc. | Tampa | Florida | 33607 | Enrolling by invitation |
| DelRicht Research (Experience Dermatology) | Atlanta | Georgia | 30329 | Recruiting |
| Dawes Fretzin Clinical Research Group, LLC | Indianapolis | Indiana | 46256 | Recruiting |
| Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | Recruiting |
| DelRicht Research @LA Dermatology Associates | Baton Rouge | Louisiana | 70809 | Recruiting |
| Minnesota Clinical Study Center | New Brighton | Minnesota | 55112 | Recruiting |
| DelRicht Research (Town Center Dermatology) | Wildwood | Missouri | 63040 | Recruiting |
| Dermatology and Laser Surgery Center | Houston | Texas | 77002 | Recruiting |
| Texas Dermatology & Laser Specialists | San Antonio | Texas | 78218 | Recruiting |
| Jordan Valley Dermatology Center | South Jordan | Utah | 84095 | Recruiting |
| Eurofins CRL Cosmetic LLC | Forest | Virginia | 24551 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07819435, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 2, 2026 · Synced Oct 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07819435 live on ClinicalTrials.gov.